{"id":1292,"date":"2019-03-14T15:54:28","date_gmt":"2019-03-14T18:54:28","guid":{"rendered":"https:\/\/phelcom.com\/?p=1292"},"modified":"2023-06-01T16:48:08","modified_gmt":"2023-06-01T19:48:08","slug":"degeneracao-macular-no-sus","status":"publish","type":"post","link":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/","title":{"rendered":"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS"},"content":{"rendered":"

Agora, os pacientes diagnosticados com Degenera\u00e7\u00e3o Macular Relacionada \u00e0 Idade (DMRI) t\u00eam mais dois novos procedimentos \u00e0 disposi\u00e7\u00e3o no Sistema \u00danico de Sa\u00fade (SUS). Isso porque o Minist\u00e9rio da Sa\u00fade ampliou os tratamentos ao incluir a oferta de medicamento antiog\u00eanico e exame de tomografia de coer\u00eancia \u00f3ptica (OCT).<\/p>\n

Os novos recursos somam-se aos j\u00e1 oferecidos pelo SUS: exame de mapeamento de retina e fotocoagula\u00e7\u00e3o \u00e0 laser. De acordo com o Minist\u00e9rio da Sa\u00fade, os novos tratamentos s\u00e3o importantes tanto para detectar precocemente a doen\u00e7a quanto para tratar os casos j\u00e1 confirmados. Dessa forma, estabiliza-se a evolu\u00e7\u00e3o do dist\u00farbio.<\/p>\n

A DMRI atinge cerca de 2,9 milh\u00f5es de pessoas no Brasil, segundo o Conselho Brasileiro de Oftalmologia (CBO). Por isso, ampliar os tratamentos \u00e9 essencial para o diagn\u00f3stico precoce e o controle da doen\u00e7a. Ent\u00e3o, conhe\u00e7a neste post quais s\u00e3o os quatro procedimentos oferecidos atualmente pelo governo e como funcionam.<\/p>\n

Degenera\u00e7\u00e3o Macular Relacionada \u00e0 Idade (DMRI)<\/h2>\n

Em primeiro lugar, entenda o que \u00e9 a Degenera\u00e7\u00e3o Macular Relacionada \u00e0 Idade (DMRI). Essa doen\u00e7a degenerativa e progressiva ocorre na parte central da retina (m\u00e1cula), \u00e1rea do olho respons\u00e1vel pela forma\u00e7\u00e3o da imagem, e leva a perda progressiva da vis\u00e3o central.<\/p>\n

O principal fator de risco para a DMRI \u00e9 o aumento da idade. Geralmente, afeta pessoas a partir dos 50 anos e \u00e9 causa mais comum de perda de vis\u00e3o nessa faixa et\u00e1ria.<\/p>\n

\"\"<\/a><\/p>\n

Degenera\u00e7\u00e3o macular no SUS: tratamentos<\/h2>\n

A DMRI n\u00e3o tem cura, mas \u00e9 poss\u00edvel conter o avan\u00e7o da doen\u00e7a com tratamentos, al\u00e9m da ado\u00e7\u00e3o de um estilo de vida mais saud\u00e1vel. Em seguida, confira quais s\u00e3o os procedimentos disponibilizados pelo SUS para detec\u00e7\u00e3o e monitoramento da DMRI:<\/p>\n

Exame de mapeamento de retina<\/h3>\n

Avalia todos os componentes situados no fundo do olho, como a retina, o nervo \u00f3ptico e o v\u00edtreo. Atualmente, \u00e9 realizado por meio de equipamentos como o oftalmosc\u00f3pio.<\/p>\n

Por\u00e9m, retin\u00f3grafos port\u00e1teis est\u00e3o chegando ao mercado para facilitar, agilizar, encurtar as dist\u00e2ncias e baixar os custos desses exames. \u00c9 o caso do Phelcom Eyer<\/a>, aparelho que funciona acoplado a um smartphone com c\u00e2mera de alta resolu\u00e7\u00e3o e integrado a uma plataforma online.<\/p>\n

\"\"<\/a>

Exame de mapeamento de retina realizado com o Phelcom Eyer.<\/p><\/div>\n

Fotocoagula\u00e7\u00e3o \u00e0 laser<\/h3>\n

Procedimento simples, r\u00e1pido e indolor que serve para reduzir o crescimento de vasos sangu\u00edneos na retina.<\/p>\n

Medicamento antiog\u00eanico<\/h3>\n

Injet\u00e1vel, pode ser feito em um ou nos dois olhos, com intervalo m\u00ednimo de 15 dias entre um olho e outro.<\/p>\n

Tomografia de coer\u00eancia \u00f3ptica (OCT)<\/h3>\n

Exame oftalmol\u00f3gico simples, n\u00e3o invasivo, para diagn\u00f3stico da doen\u00e7a nos dois olhos. Visa detectar sinais microsc\u00f3picos de altera\u00e7\u00f5es precoces da retina, j\u00e1 que permite observ\u00e1-la em detalhes e pode medir o edema.<\/p>\n

Os dois novos procedimentos disponibilizados pelo SUS atender\u00e3o pacientes a partir dos 60 anos, conforme Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Degenera\u00e7\u00e3o Macular Relacionada \u00e0 Idade, do Minist\u00e9rio da Sa\u00fade.<\/p>\n

Conclus\u00e3o<\/h2>\n

Sem d\u00favida, \u00e9 fundamental o aumento de op\u00e7\u00f5es de tratamentos para degenera\u00e7\u00e3o macular no SUS. A inclus\u00e3o do medicamento antiog\u00eanico e da tomografia de coer\u00eancia \u00f3ptica (OCT) ajudar\u00e1 a aumentar o n\u00famero de diagn\u00f3sticos precoces e os casos de estabiliza\u00e7\u00e3o da doen\u00e7a. Al\u00e9m disso, tamb\u00e9m deve diminuir as filas de espera.<\/p>\n

Quer ficar por dentro de todas as novidades na \u00e1rea de oftalmologia? Inscreva-se na nossa newsletter.<\/p>\n","protected":false},"excerpt":{"rendered":"

Tomografia de coer\u00eancia \u00f3ptica (OCT), exame para diagn\u00f3stico, e medicamento antiog\u00eanico, para estabilizar evolu\u00e7\u00e3o da doen\u00e7a, passam a ter cobertura pelo SUS.<\/p>\n","protected":false},"author":3,"featured_media":1293,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[107],"tags":[],"class_list":["post-1292","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude"],"acf":[],"yoast_head":"\nConhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS - PHELCOM Technologies<\/title>\n<meta name=\"description\" content=\"A OCT e o medicamento antiog\u00eanico s\u00e3o os novos procedimentos para diagn\u00f3stico e controle da degenera\u00e7\u00e3o macular no SUS. Veja neste post\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS - PHELCOM Technologies\" \/>\n<meta property=\"og:description\" content=\"A OCT e o medicamento antiog\u00eanico s\u00e3o os novos procedimentos para diagn\u00f3stico e controle da degenera\u00e7\u00e3o macular no SUS. Veja neste post\" \/>\n<meta property=\"og:url\" content=\"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/\" \/>\n<meta property=\"og:site_name\" content=\"PHELCOM Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/phelcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-14T18:54:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-01T19:48:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/phelcom.com\/wp-content\/uploads\/2019\/03\/Degeneraca-macular-SUS.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"555\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gabriela Marques\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriela Marques\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/\"},\"author\":{\"name\":\"Gabriela Marques\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/person\\\/4e0e58359256b5df6d71d632d2fbdd20\"},\"headline\":\"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS\",\"datePublished\":\"2019-03-14T18:54:28+00:00\",\"dateModified\":\"2023-06-01T19:48:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/\"},\"wordCount\":619,\"publisher\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/Degeneraca-macular-SUS.jpg\",\"articleSection\":[\"Sa\u00fade\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/\",\"name\":\"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS - PHELCOM Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/Degeneraca-macular-SUS.jpg\",\"datePublished\":\"2019-03-14T18:54:28+00:00\",\"dateModified\":\"2023-06-01T19:48:08+00:00\",\"description\":\"A OCT e o medicamento antiog\u00eanico s\u00e3o os novos procedimentos para diagn\u00f3stico e controle da degenera\u00e7\u00e3o macular no SUS. Veja neste post\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#primaryimage\",\"url\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/Degeneraca-macular-SUS.jpg\",\"contentUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/Degeneraca-macular-SUS.jpg\",\"width\":1080,\"height\":555},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/blog\\\/saude\\\/degeneracao-macular-no-sus\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/\",\"name\":\"PHELCOM Technologies\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#organization\",\"name\":\"Phelcom\",\"url\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/color_horizontal.png\",\"contentUrl\":\"https:\\\/\\\/phelcom.com\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/color_horizontal.png\",\"width\":245,\"height\":40,\"caption\":\"Phelcom\"},\"image\":{\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/phelcom\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/phelcom-technologies\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCSZCLEV9ZrbGBie0R0IxQpA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/phelcom.com\\\/pt-br\\\/en\\\/#\\\/schema\\\/person\\\/4e0e58359256b5df6d71d632d2fbdd20\",\"name\":\"Gabriela Marques\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS - PHELCOM Technologies","description":"A OCT e o medicamento antiog\u00eanico s\u00e3o os novos procedimentos para diagn\u00f3stico e controle da degenera\u00e7\u00e3o macular no SUS. Veja neste post","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/","og_locale":"pt_BR","og_type":"article","og_title":"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS - PHELCOM Technologies","og_description":"A OCT e o medicamento antiog\u00eanico s\u00e3o os novos procedimentos para diagn\u00f3stico e controle da degenera\u00e7\u00e3o macular no SUS. Veja neste post","og_url":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/","og_site_name":"PHELCOM Technologies","article_publisher":"https:\/\/www.facebook.com\/phelcom\/","article_published_time":"2019-03-14T18:54:28+00:00","article_modified_time":"2023-06-01T19:48:08+00:00","og_image":[{"width":1080,"height":555,"url":"https:\/\/phelcom.com\/wp-content\/uploads\/2019\/03\/Degeneraca-macular-SUS.jpg","type":"image\/jpeg"}],"author":"Gabriela Marques","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gabriela Marques","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#article","isPartOf":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/"},"author":{"name":"Gabriela Marques","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/person\/4e0e58359256b5df6d71d632d2fbdd20"},"headline":"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS","datePublished":"2019-03-14T18:54:28+00:00","dateModified":"2023-06-01T19:48:08+00:00","mainEntityOfPage":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/"},"wordCount":619,"publisher":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#primaryimage"},"thumbnailUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2019\/03\/Degeneraca-macular-SUS.jpg","articleSection":["Sa\u00fade"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/","url":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/","name":"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS - PHELCOM Technologies","isPartOf":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#primaryimage"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#primaryimage"},"thumbnailUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2019\/03\/Degeneraca-macular-SUS.jpg","datePublished":"2019-03-14T18:54:28+00:00","dateModified":"2023-06-01T19:48:08+00:00","description":"A OCT e o medicamento antiog\u00eanico s\u00e3o os novos procedimentos para diagn\u00f3stico e controle da degenera\u00e7\u00e3o macular no SUS. Veja neste post","breadcrumb":{"@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#primaryimage","url":"https:\/\/phelcom.com\/wp-content\/uploads\/2019\/03\/Degeneraca-macular-SUS.jpg","contentUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2019\/03\/Degeneraca-macular-SUS.jpg","width":1080,"height":555},{"@type":"BreadcrumbList","@id":"https:\/\/phelcom.com\/pt-br\/blog\/saude\/degeneracao-macular-no-sus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/phelcom.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Conhe\u00e7a os novos tratamentos para degenera\u00e7\u00e3o macular no SUS"}]},{"@type":"WebSite","@id":"https:\/\/phelcom.com\/pt-br\/en\/#website","url":"https:\/\/phelcom.com\/pt-br\/en\/","name":"PHELCOM Technologies","description":"","publisher":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/phelcom.com\/pt-br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/phelcom.com\/pt-br\/en\/#organization","name":"Phelcom","url":"https:\/\/phelcom.com\/pt-br\/en\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/logo\/image\/","url":"https:\/\/phelcom.com\/wp-content\/uploads\/2018\/07\/color_horizontal.png","contentUrl":"https:\/\/phelcom.com\/wp-content\/uploads\/2018\/07\/color_horizontal.png","width":245,"height":40,"caption":"Phelcom"},"image":{"@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/phelcom\/","https:\/\/www.linkedin.com\/company\/phelcom-technologies","https:\/\/www.youtube.com\/channel\/UCSZCLEV9ZrbGBie0R0IxQpA"]},{"@type":"Person","@id":"https:\/\/phelcom.com\/pt-br\/en\/#\/schema\/person\/4e0e58359256b5df6d71d632d2fbdd20","name":"Gabriela Marques"}]}},"_links":{"self":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/1292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/comments?post=1292"}],"version-history":[{"count":0,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/posts\/1292\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/media\/1293"}],"wp:attachment":[{"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/media?parent=1292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/categories?post=1292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/phelcom.com\/pt-br\/wp-json\/wp\/v2\/tags?post=1292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}